Literature DB >> 9175586

Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury.

M Raza1, A M Al-Bekairi, A M Ageel, S Qureshi.   

Abstract

Mice fed with sodium valproate for 7, 14 and 21 days were evaluated for hepatotoxicity and renal tubular disorder. The drug was administered as an aqueous solution with an increasing concentration up to five days gradually reaching up to 0.71% w/v, which persisted throughout the study period. Mice fed with sodium valproate for 7, 14 and 21 days showed, marked hepatic injury and renal tubular disorder, evidenced by increased levels of malondialdehyde as a measure of lipid peroxidation. Administration of sodium valproate affected the glutathione contents both in liver and kidney tissue at all the three time points. However, this reduction in glutathione concentration was more pronounced in kidney when compared to control group. These results support the hypothesis that lipid peroxidation mediates the effect of sodium valproate on liver and kidney. Furthermore, the valproate induced toxicity is time related and the increase in lipid peroxide levels and depletion of glutathione occur time dependent even if the dose is clinically appropriate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175586     DOI: 10.1006/phrs.1997.0134

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Risk factors for sodium valproate-induced renal tubular dysfunction.

Authors:  Satoko Koga; Takahisa Kimata; Sohsaku Yamanouchi; Shoji Tsuji; Ken Yoshimura; Atsushi Araki; Kazunari Kaneko
Journal:  Clin Exp Nephrol       Date:  2017-08-23       Impact factor: 2.801

2.  Valproic Acid Protects Against Acute Kidney Injury in Hemorrhage and Trauma.

Authors:  Ben E Biesterveld; Ali Z Siddiqui; Rachel L O'Connell; Henriette Remmer; Aaron M Williams; Alizeh Shamshad; William M Smith; Michael T Kemp; Glenn K Wakam; Hasan B Alam
Journal:  J Surg Res       Date:  2021-05-20       Impact factor: 2.417

Review 3.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

4.  Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen.

Authors:  Marwa A Abdel-Dayem; Ahmed A Elmarakby; Azza A Abdel-Aziz; Chelsey Pye; Shehta A Said; Abdalla M El-Mowafy
Journal:  Drugs R D       Date:  2014-06

5.  The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo.

Authors:  Maria J Klomp; Leo J Hofland; Lilian van den Brink; Peter M van Koetsveld; Fadime Dogan; Corrina M A de Ridder; Debra C Stuurman; Marian C Clahsen-van Groningen; Marion de Jong; Simone U Dalm
Journal:  Pharmaceutics       Date:  2022-01-12       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.